Events

Recall Or Safety Alert for LIAISON® Estradiol II Gen. Assay

According to Agencia Española de Medicamentos y Productos Sanitarios (Via FOI), this recall or safety alert involved a device in Spain that was produced by DiaSorin Inc..

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Recall / Safety Alert
  • Date
    2016-08-09
  • Event Country
    Spain
  • Event Source
    AEMPSVFOI
  • Notes / Alerts
    The data from Spain is current through June 2018. All of the data comes from Agencia Española de Medicamentos y Productos Sanitarios, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Spain.
  • Extra notes in the data
  • Action
    Cross reactivity of the drug Fulvestrant (Faslodex®) with the LIAISON® Estradiol II Gen assay, reference number 310680, manufactured by DiaSorin Inc. US, in the United States, so that falsely elevated estradiol results could be obtained.

Device

LIAISON® Estradiol II Gen. Assay

Manufacturer

DiaSorin Inc.